抗凝逆转药物市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00004954
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

抗凝逆转药物市场规模预计将从 2023 年的 13.064 亿美元增至 2031 年的 24.4287 亿美元。预计 2023-2031 年市场复合年增长率为 10.08%。创新产品的开发和推出可能仍是抗凝逆转药物市场的主要趋势。

抗凝逆转药物市场分析

近年来,抗凝剂的使用越来越多,用于预防和治疗各种心血管疾病,如肺栓塞 (PE)、深静脉血栓形成 (DVT)、心房颤动 (AF)、机械性心脏瓣膜血栓形成和急性冠状动脉综合征。然而,这些治疗方法的广泛使用存在大出血和小出血的风险,导致住院和急诊就诊。如果患者被处方由抗凝剂和抗血小板或双重抗血小板疗法组成的联合疗法,这种风险可能会增加。单独使用时,华法林和阿司匹林的出血风险最高。因此,抗凝逆转药物可用于预防出血。心房颤动 (AFib) 患病率的上升和中风发病率的增加预计将有利于开发新的治疗方法来改善言语能力。

抗凝逆转药物市场概况

美国疾病控制与预防中心 (CDC) 指出,美国每年有超过 454,000 例房颤相关住院病例,导致约 158,000 人死亡。此外,房颤风险会随着年龄增长而增加,高血压也是房颤病例中约 1/5 的病因之一,而高血压也随着年龄增长而变得更加常见。老年人口的增加预计将在未来十年带来对抗凝逆转药物的需求增长。

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

抗凝逆转药物市场:

Anticoagulant Reversal Drugs Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

抗凝逆转药物市场驱动因素和机遇

神经退行性疾病和言语障碍治疗市场前景看好

抗凝逆转药物用于治疗出血性中风,以减少持续出血并使组织恢复。中低收入国家的中风患病率有所上升。根据中风意识基金会的数据,美国每年约有 795,000 人中风,每年导致超过 140,000 人死亡。其中,约 40% 的中风相关死亡发生在男性中,其余 60% 发生在女性中。在 2021 年 5 月《姑息医学年鉴》(APM)发表的一篇文章中,对一名接受华法林治疗的急性缺血性中风 (AIS) 患者施用了 4 因子凝血酶原复合物浓缩物、新鲜冷冻血浆和维生素 K1 的组合。该报告显示,对于患有华法林相关高凝状态的 AIS 患者,神经系统得到改善,凝血成功逆转。因此,中风发病率的上升是抗凝逆转药物市场份额的主要驱动力。

增加研究活动——开发新型抗凝逆转药物的机会

为了应对日益流行的心血管疾病(如心房颤动),全球范围内新型疗法药物开发的研究活动正在迅速推进,这推动了抗凝逆转药物市场的增长。在治疗各种心血管疾病时,始终需要创新的治疗方法。例如,2020 年 7 月在《血栓与止血杂志》上发表的题为“评估 andexanet alfa 和四因子凝血酶原复合物浓缩物 (4F-PCC) 对利伐沙班和阿哌沙班相关颅内出血的逆转作用”的研究是在马萨诸塞州总医院进行的,旨在研究 andexanet alfa 在治疗颅内出血 (ICH) 方面的疗效。因此,越来越多的研究活动正在推动药物发现活动,并为整个行业的市场增长提供有利可图的机会。

抗凝逆转药物市场报告细分分析

有助于抗凝逆转药物市场分析的关键部分是产品和分销渠道。

  • 根据产品,抗凝逆转药物市场分为凝血酶原复合物浓缩物、维生素 K、鱼精蛋白、氨甲环酸、依达赛珠单抗和 AndeXXa。凝血酶原复合物浓缩物部分在 2023 年占据了最大的市场份额。
  • 就分销渠道而言,抗凝逆转药物市场分为医院药房、零售药房和其他。医院药房部分在 2023 年占据了最大的市场份额。

抗凝逆转药物市场份额按地区分析

抗凝逆转药物市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。

北美主导了抗凝逆转药物市场。在北美,美国是抗凝逆转药物的最大市场。该市场的增长主要受到心房颤动等心血管疾病日益流行的推动,市场参与者的发展以及美国主要市场参与者的存在将加速该市场在美国的增长。此外,美国市场参与者的战略发展可能会有利于市场的增长。例如,2023 年 6 月,阿斯利康在美国和欧盟为其 Andexxa (andexanet alfa) 进行了全面的监管备案,从而超越了目前的有条件批准。Andexxa 是一种可以快速逆转直接口服 FXa 抑制剂抗凝作用的治疗方法。多个学科的 15 多个国家和国际指南支持其使用。阿斯利康现在正在美国进行全面标签批准的监管备案。

 

抗凝逆转药物市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响抗凝逆转药物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的抗凝逆转药物市场细分和地理位置。

Anticoagulant Reversal Drugs Market
  • 获取抗凝逆转药物市场的区域特定数据

抗凝逆转药物市场报告范围

报告属性细节
2023 年的市场规模13.064亿美元
2031 年市场规模24.4287亿美元
全球复合年增长率(2023 - 2031)10.08%
史料2021-2022
预测期2024-2031
涵盖的领域按产品
  • 凝血酶原复合物浓缩物
  • 维生素K
  • 鱼精蛋白
  • 氨甲环酸
  • 伊达珠单抗
  • 安德西卡
按产品
  • 凝血酶原复合物浓缩物
  • 维生素K
  • 鱼精蛋白
  • 氨甲环酸
  • 伊达珠单抗
  • 安德西卡
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 赛诺菲,
  • 强生公司,
  • 葛兰素史克,
  • 博士伦健康,
  • 武田制药
  • Lexicon Pharmaceuticals, Inc.
  • 武田制药
  • 艾伯维(AbbVie)公司

市场参与者密度:了解其对商业动态的影响

抗凝逆转药物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在抗凝逆转药物市场运营的主要公司有:

  1. 赛诺菲,
  2. 强生公司,
  3. 葛兰素史克,
  4. 博士伦健康,
  5. 武田制药
  6. Lexicon Pharmaceuticals, Inc.

免责声明上面列出的公司没有按照任何特定顺序排列。


Anticoagulant Reversal Drugs Market

 

  • 了解抗凝逆转药物市场的主要参与者概况

抗凝逆转药物市场新闻和最新发展

抗凝逆转药物市场通过收集来自一级和二级研究的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是言语和语言障碍市场的发展和策略列表:

  • 阿斯利康制药印度有限公司宣布,该公司已获得印度中央药品标准管理组织 (CDSCO) 的批准,可以进口和销售 Andexanet Alfa。这种治疗方法可有效治疗使用 Xa 因子 (FXa) 抑制剂引起的危及生命或难治性出血。(来源:阿斯利康制药,新闻稿,2024 年)
  • Octapharma USA 宣布 Balfaxar 获得美国食品药品监督管理局 (FDA) 批准。Balfaxar 是一种非活性四因子凝血酶原复合物浓缩物 (4F-PCC),含有维生素 K 依赖性因子:因子 II(凝血酶原)、因子 VII、因子 IX 和因子 X,以及抗血栓蛋白 C 和 S。它可用于紧急逆转由维生素 K 拮抗剂 (VKA) 治疗引起的获得性凝血因子缺乏,适用于需要紧急手术或侵入性操作的成年患者。Balfaxar 通过补充华法林治疗导致的凝血因子缺乏水平来帮助恢复血液凝固。(来源:Octapharma USA, Inc,新闻稿,2023 年)

抗凝逆转药物市场报告覆盖范围和交付成果

“抗凝逆转药物市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.